prostate cancer

Treatment isn’t always needed for older male patients with prostate cancer and a short life expectancy, according to researchers at the Yale School of Medicine.

Read More|Comment

Metabolic syndrome does not raise a mans risk of developing prostate cancer overall, but does raise their risk of aggressive prostate cancer, according to a report presented at the 27th Annual Congress of the European Association of Urology.

Read More|Comment

A new study suggests men screened for cancer using the prostate specific antigen (PSA) blood test reduces the number of prostate cancer deaths.

Read More|Comment

Cancer rates for lung, prostate and colon cancer has dropped significantly for men in the United States, according to the latest Cancer Facts & Figures report from the American Cancer Society.

Read More|Comment

A new study shows that when men with prostate cancer were diagnosed after developing symptoms rather than after screening tests, they had a higher risk of dying from heart problems or other cancers rather than the prostate cancer itself.

Read More|Comment

Love to eat curry? It may do more than tingle your tastebuds.

According to a new study, curry spice components may help slow the growth of tumors in castration-resistant prostate cancer patients.

Read More|Comment

Researchers at Duke Cancer Institute found a proven link between coronary artery disease and prostate cancer, indicating the two ailments may have joint causes.

Read More|Comment

New research finds an experimental prostate cancer drug that works differently than other treatments actually extends the lives of men with spreading cancer by an average of nearly five months.

Read More|Comment

Avodart, a popular drug used to treat an enlarged prostate gland could have an additional benefit. Research shows it helps slow the progression of early-stage prostate cancer, thus reducing the need for aggressive treatment in some men.

Read More|Comment

Regular cancer screenings are sometimes touted as life-saving measures, but a new study finds there was no mortality benefit for men who had prostate cancer screenings compared with those who didn’t.

Read More|Comment